Vanguard Total Stock Market ETF (VTI)
343.08
+0.00 (0.00%)
NYSE · Last Trade: Jan 29th, 5:46 AM EST
Detailed Quote
| Previous Close | 343.08 |
|---|---|
| Open | - |
| Day's Range | N/A - N/A |
| 52 Week Range | 236.42 - 344.42 |
| Volume | 357 |
| Market Cap | 5.65B |
| Dividend & Yield | 3.804 (1.11%) |
| 1 Month Average Volume | 6,477,417 |
Chart
News & Press Releases
JOBY Stock Is Falling Pre-Market — What Is Dragging The Electric Air Taxi Developer's Shares Down?stocktwits.com
Via Stocktwits · January 29, 2026
The U.S. Food and Drug Administration cleared its Investigational New Drug application for SER-252, a therapy to treat patients with Parkinson’s disease.
Via Stocktwits · January 29, 2026
The company now eyes 2026 capital expenditure of about $20 billion, up from the $8.5 billion reported in 2025.
Via Stocktwits · January 28, 2026
Microsoft reported a marginal decline in the growth of its cloud-computing unit while the company’s capital expenditure increased about 66% year-on-year.
Via Stocktwits · January 28, 2026
CALC Stock Slumped 76% On Wednesday — Here’s Whystocktwits.com
Via Stocktwits · January 28, 2026
Tesla Q4 Earnings Beats Wall Street Expectationsstocktwits.com
Via Stocktwits · January 28, 2026
BNAI Stock Again Soars More Than 40% — What’s The Latest Update Driving The Relentless Rally?stocktwits.com
Via Stocktwits · January 28, 2026
Why Is Richtech Robotics Stock Falling One Day After Announcing A Deal With Microsoft?stocktwits.com
Via Stocktwits · January 28, 2026
Tesla Brand Value Reportedly Took A Dive In 2025 Owing To Elon Musk’s Politicsstocktwits.com
Via Stocktwits · January 27, 2026
Invesco BulletShares 2027 Corporate Bond ETF tracks a portfolio of investment-grade corporate bonds maturing in 2027, targeting defined income and principal return at maturity.
Via The Motley Fool · January 28, 2026
REGENXBIO stated that the FDA has placed a clinical hold on the company’s experimental gene therapy program for the treatment of rare childhood diseases.
Via Stocktwits · January 28, 2026
Under the terms of the deal between Seamless Therapeutics and Eli Lilly, Seamless will design and program site-specific enzymes to correct mutations in certain genes related to hearing loss.
Via Stocktwits · January 28, 2026
The right investment can help protect against potential market volatility.
Via The Motley Fool · January 28, 2026
Why DID CVM Shares Rally Over 7% Today?stocktwits.com
Via Stocktwits · January 26, 2026
IonQ Said To Buy SkyWater For $1.8 Billion In Push Toward Domestic Quantum Hardwarestocktwits.com
Via Stocktwits · January 26, 2026
GE Vernova now expects 2026 revenue of $44–$45 billion, up from $41–$42 billion, and lifted its 2028 revenue target to $56 billion from $52 billion.
Via Stocktwits · January 28, 2026
According to TheFly, analysts at Rothschild & Co Redburn downgraded PayPal to ‘Sell’ from ‘Neutral’ and lowered the price target to $50 from $70.
Via Stocktwits · January 28, 2026
Richtech Robotics has partnered with Microsoft, and both companies have worked to upgrade Richtech’s ADAM robot using Azure AI technologies.
Via Stocktwits · January 27, 2026
The company tied up with Davidson Technologies and defense company Anduril Industries to develop quantum-classical hybrid applications for U.S. air and missile defense scenarios.
Via Stocktwits · January 27, 2026
Brand Engagement Network shot into the retail spotlight after announcing an AI licensing partnership deal in South Africa last week.
Via Stocktwits · January 26, 2026
This fund is a perfect example of buying the haystack instead of seeking the needle.
Via The Motley Fool · January 26, 2026
Battalion has entered into a gas treating agreement with a publicly traded large-cap midstream company, bringing the stock under retail traders’ radar.
Via Stocktwits · January 26, 2026
According to Bate’s Linkedin, he is now plant manager at Redwood-city-based electric thermal management and sensing solutions provider Chemelex.
Via Stocktwits · January 26, 2026
The chip brings increased memory, data flow, and compute capabilities to Microsoft’s cloud infrastructure and aids the company’s push to support advanced AI workloads.
Via Stocktwits · January 26, 2026
The U.S. stock market is experiencing a big rotation in 2026 that's been great for small caps and cyclicals, but not so much for tech. That makes this Vanguard ETF an ideal pick-up in the new year.
Via The Motley Fool · January 24, 2026
